(Q43179196)

15 November 2017

Targeted therapies: optimal first-line therapy for NSCLC with EGFR mutations (English)

1 reference

non-small-cell lung carcinoma

15 November 2017

1 reference

2

Lecia V Sequist

1 reference

15 November 2017

Joel W Neal

1

1 reference

PubMed ID

20118973

15 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Nature Reviews Clinical Oncology

15 November 2017

1 reference

15 November 2017

7

1 reference

15 November 2017

2

1 reference

15 November 2017

71-72

1 reference

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

15 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.191

Erlotinib in previously treated non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.191

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.191

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.191

Epidermal growth factor receptor mutations in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.191

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.191

Screening for epidermal growth factor receptor mutations in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.191

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.191

Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.191

10.1038/NRCLINONC.2009.191

31 March 2020

Identifiers

DOI

1 reference

15 November 2017

1 reference

PubMed ID

20118973